Ozanimod
Back to searchMolecule Structure
Scientific Name
Ozanimod
Description of the Drug
Ozanimod is a sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12612
http://www.drugbank.ca/drugs/DB12612
Brand Name(s)
Not Available
Company Owner(s)
Celgene International Ii Sarl
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sphingosine 1-phosphate receptor Edg-1 | SINGLE PROTEIN | MODULATOR | CHEMBL4333 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2195490 | |
| DrugBank | DB12612 | |
| PubChem: Thomson Pharma | 123078507 | |
| PubChem | 52938427 | |
| Nikkaji | J3.612.016I | |
| PDBe | JEU | |
| BindingDB | 50507186 | |
| DrugCentral | 5383 | |
| ChemicalBook | CB42716147 | |
| Guide to Pharmacology | 8709 | |
| rxnorm | OZANIMOD | OZANIMOD HYDROCHLORIDE |
| ZINC | ZINC000116109867 |
